Ondansetron
- Product NDC
- 53002-0591
- 11-digit product format
- 530020591
- Labeler code
- 53002
- Product ID
- 53002-0591_4c58826f-793d-4cd8-97c5-b12072a6db23
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA090469
- Marketing category
- ANDA
- Marketing start
- 2010-04-12
- Marketing end
- 0000-00-00
- Substance
- ONDANSETRON
- Active strength
- 8 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53002-0591-1 | 2025-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-2 | 2025-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-3 | 2025-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-4 | 2025-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-1 | 2023-06-07 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-2 | 2023-06-07 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-3 | 2023-06-07 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-4 | 2023-06-07 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-2 | 2023-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-3 | 2023-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
| 53002-0591-4 | 2023-01-30 | C162847 | 48780-1 | f386c649-e34d-0266-e053-dadaa90a7c1a | These highlights do not include all the information needed to use ONDANSETRON ORALLY DISINTEGRATING TABLETS, safely and effectively. See full prescribing information for ONDANSETRON ORALLY DISINTEGRATING TABLETS. ONDANSETRON orally disintegrating tablets Initial U.S. Approval: 1991 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-0591-1 | Ondansetron | 3 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 3 | | 3 |
| 53002-0591-2 | Ondansetron | 6 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 6 | | 3 |
| 53002-0591-3 | Ondansetron | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | | 3 |
| 53002-0591-4 | Ondansetron | 30 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-0591 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [RPK PHARMACEUTICALS, INC.] | 3 | Legacy NDC, 4 package rows | 20230609_c0640556-ae39-4b57-9030-03a23dcdb60c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-0591-1 | 53002059101 | 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (53002-0591-1) | 2020-01-01 | 0000-00-00 | No | No | Current |
| 53002-0591-2 | 53002059102 | 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (53002-0591-2) | 2020-01-01 | 0000-00-00 | No | No | Current |
| 53002-0591-3 | 53002059103 | 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (53002-0591-3) | 2020-01-01 | 0000-00-00 | No | No | Current |
| 53002-0591-4 | 53002059104 | 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (53002-0591-4) | 2020-01-01 | 0000-00-00 | No | No | Current |